Veranex, Inc.

Veranex is the world's first global Innovation Contract Research Organization (iCRO) providing integrated product development and contract research services for medical device and in-vitro diagnostic companies. Founded in 2021 but with a legacy over 20 years, Veranex combines design engineering, preclinical research, clinical trials, regulatory affairs, quality consulting, manufacturing, and market access services under one roof. This integrated approach eliminates traditional handoffs between development phases, reducing timelines and budget variance for clients. The company serves medical device innovators from early-stage startups to global strategics across cardiovascular, neurovascular, ophthalmology, and diagnostic markets. With more than 800 specialists across North America, Europe, and Asia-Pacific, Veranex has supported over 1,000 device programs and 2,500 clinical trials (preclinical-feasibility and pivotal). Headquartered in Raleigh, North Carolina, Veranex operates facilities in the US, Europe and Asia-Pacific with 15+ innovation and research centers. For more information, visit https://veranex.com/